These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 968087

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A, Vacca U, Pirro R, Cerone G.
    Clin Ter; 1975 Aug 15; 74(3):265-70. PubMed ID: 1227747
    [No Abstract] [Full Text] [Related]

  • 3. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F.
    Curr Ther Res Clin Exp; 1976 Mar 15; 19(3):337-8. PubMed ID: 817863
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
    Glasgow GL, Henley JW, Willoughby EW.
    Aust N Z J Med; 1974 Aug 15; 4(4):373-8. PubMed ID: 4278910
    [No Abstract] [Full Text] [Related]

  • 6. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].
    Martínez-Lage JM, Burguera JA, Deldago G, Zubieta JL.
    Arch Neurobiol (Madr); 1978 Aug 15; 41(1):3-18. PubMed ID: 697513
    [No Abstract] [Full Text] [Related]

  • 7. Sinemet.
    Drug Ther Bull; 1974 Oct 11; 12(21):83-4. PubMed ID: 4617660
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R.
    Neurol Neurocir Psiquiatr; 1976 Oct 11; 17(4):293-300. PubMed ID: 1018729
    [Abstract] [Full Text] [Related]

  • 9. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
    Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS.
    Drugs; 1976 Oct 11; 11(5):329-77. PubMed ID: 782834
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L, De la Garza R.
    Arch Invest Med (Mex); 1977 Oct 11; 8(2):123-8. PubMed ID: 907417
    [Abstract] [Full Text] [Related]

  • 11. Paradoxial response to dopaminergic agents in parkinsonism.
    Wiener WJ, Kramer J, Nausieda PA, Klawans HL.
    Arch Neurol; 1978 Jul 11; 35(7):453-5. PubMed ID: 666596
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. L-dopa and carbidopa (sinemet) in the management of parkinsonism.
    Critchley E.
    Postgrad Med J; 1975 Sep 11; 51(599):619-21. PubMed ID: 1105500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug therapy for Parkinsonism.
    Walker E.
    Mod Healthc (Short Term Care); 1976 Jan 11; 5(1):62. PubMed ID: 1652
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of levodopa with carbidopa or benserazide in parkinsonism.
    Greenacre JK, Coxon A, Petrie A, Reid JL.
    Lancet; 1976 Aug 21; 2(7982):381-4. PubMed ID: 73849
    [Abstract] [Full Text] [Related]

  • 20. Drug therapy of Parkinsonism dopaminergic drugs.
    Bianchine JR.
    Ohio State Med J; 1977 Feb 21; 73(2):84-5. PubMed ID: 834419
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.